P Liebisch, S Eppinger, C Schopflin, G Stehle, G Munzert, H Dohner, M Schmid. CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q. Haematologica 2005;90(4):489-493; https://doi.org/10.3324/%x.